Becton Dickinson Aug 4, 2022 Becton Dickinson Attributes Q3 Core Growth to Macro Headwind Mitigation Premium Jul 26, 2022 Concerns Around STD Testing on the Rise as Infection Rates Climb During Pandemic Premium Jun 30, 2022 Becton Dickinson Gets CE-IVD Mark for BD Max Combined COVID, Flu, RSV Panel Jun 9, 2022 Abbott, Cepheid, BD, Roche, Others Nab FDA 510(k) Clearances in May May 26, 2022 Becton Dickinson Gets CE-IVD Mark for High-Throughput COVID/Flu PCR Test May 13, 2022 In Brief This Week: Labcorp, Lucid Diagnostics, Seegene, Babson Diagnostics, Danaher, More May 5, 2022 Becton Dickinson Fiscal Q2 Revenues Grow 2 Percent Apr 29, 2022 In Brief This Week: Mayo Clinic, Quest Diagnostics, Castle Bio, Becton Dickinson, PerkinElmer, More Apr 6, 2022 As COVID-19 Sales Retreat, Diagnostic Firms Turn Attention to Core Businesses Premium Mar 10, 2022 FDA Issues Clearances to Cepheid, Becton Dickinson, BioMérieux, Others in February Mar 1, 2022 360Dx Top 30 Remains Essentially Flat in February Feb 9, 2022 Day Zero Diagnostics Closes $21M VC Financing Round Feb 4, 2022 In Brief This Week: Becton Dickinson, Proscia, Co-Diagnostics, Biocept, and More Feb 3, 2022 Becton Dickinson Q1 Revenues Fall 6 Percent, Beat Estimates Feb 1, 2022 360Dx Top 30 Plummets 17 Percent in January Feb 1, 2022 Becton Dickinson Acquires Spanish Clinical Flow Cytometry Firm Cytognos Jan 28, 2022 In Brief This Week: Becton Dickinson, PerkinElmer, and Trinity Biotech Jan 12, 2022 JP Morgan Healthcare Conference Day 2: Labcorp, Thermo Fisher Scientific, Abbott, Danaher, More Jan 11, 2022 BD Partners With Pfizer, Wellcome to Study Role of Diagnostics in Antimicrobial Resistance Jan 7, 2022 Becton Dickinson Receives FDA 510(k) Clearance for Robotic Colony Picking and Sample Prep Kiestra Module Load More Breaking News BARDA Provides Additional $3.7M to T2 Biosystems Under Contract Option Careviso Closes $17.4M Series B Funding Round P4 Diagnostix, Pierian Partner to Offer Somatic Prostate Cancer Testing MiRxes Launches Study for Pulmonary Hypertension Biomarkers in Asian Populations OraSure Technologies Awarded $8.6M BARDA Contract for Next-Gen Ebola Test BioAffinity Technologies Nabs $15.6M from Public Offering
